3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
5
Uterine Cervical Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasm Metastasis
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Kidney Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Cystadenocarcinoma, Serous
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Advanced Renal Cell Carcinoma (RCC)
1
Advanced Non-small Cell Lung Cancer
1
Adenocarcinoma, Mucinous
1
Interventions
Carboplatin
29
pembrolizumab
25
Pemetrexed
25
Specimen Handling
22
Cisplatin
20
Magnetic Resonance Spectroscopy
18
Paclitaxel
15
Gemcitabine
13
Docetaxel
12
durvalumab
9
Nivolumab
8
osimertinib
7
Taxes
7
Immunoglobulin G
7
Disulfides
7
130-nm albumin-bound paclitaxel
7
atezolizumab
6
Etoposide
6
Platinum
5
Cetuximab
5
1,2-diaminocyclohexaneplatinum II citrate
5
X-Rays
4
Ramucirumab
4
Radiotherapy
4
Radiation
4
Observation
4
Interviews as Topic
4
Biopsy
4
Albumin-Bound Paclitaxel
4
patritumab deruxtecan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Axitinib
×
30 days
×
Clear all
No trials found.